Market Cap 690.26M
Revenue (ttm) 0.00
Net Income (ttm) -51.99M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 502,000
Avg Vol 464,408
Day's Range N/A - N/A
Shares Out 54.52M
Stochastic %K 20%
Beta N/A
Analysts Strong Sell
Price Target $41.60

Latest News on BCAX

Bicara Therapeutics targets $265 mln proceeds in upsized US IPO

Sep 11, 2024, 6:34 PM EDT - 7 months ago

Bicara Therapeutics targets $265 mln proceeds in upsized US IPO


Bicara Therapeutics IPO Registration Document (S-1)

Aug 22, 2024, 4:38 PM EDT - 7 months ago

Bicara Therapeutics IPO Registration Document (S-1)